Harrow Health (NASDAQ:HROW – Get Rating) and HCW Biologics (NASDAQ:HCWB – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations. Risk and Volatility Harrow Health has a beta of […]
Corrado Advisors LLC lessened its holdings in shares of Harrow Health, Inc. (NASDAQ:HROW – Get Rating) by 14.9% during the fourth quarter, HoldingsChannel reports. The fund owned 16,314 shares of the company’s stock after selling 2,846 shares during the period. Corrado Advisors LLC’s holdings in Harrow Health were worth $241,000 at the end of the […]
Harrow Health (NASDAQ:HROW – Get Rating) is scheduled to release its earnings data after the market closes on Thursday, May 11th. Analysts expect Harrow Health to post earnings of ($0.05) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Harrow Health Stock Up […]
Harrow Health, Inc. (NASDAQ:HROW – Get Rating)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $28.25 and last traded at $26.89, with a volume of 77630 shares. The stock had previously closed at $28.08. Analyst Upgrades and Downgrades A number of brokerages have recently issued […]
B. Riley reissued their buy rating on shares of Harrow Health (NASDAQ:HROW – Get Rating) in a research note published on Thursday, PriceTargets.com reports. B. Riley also issued estimates for Harrow Health’s FY2026 earnings at $4.27 EPS and FY2027 earnings at $6.22 EPS. A number of other analysts also recently issued reports on the stock. […]